All Stories

Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance its pipeline of non-opioid pain management drugs.

Mar 17, 2025 - 10:13
 0
Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic
Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance its pipeline of non-opioid pain management drugs.
Read More

Tags:

Previous Article

$4,750 Rentals in Los Angeles

Next Article

Construction of KF‐Rich Solid Electrolyte Interfaces Based on the Electrodeposit...

Related Posts

Fierce Biotech Layoff Tracker 2025: Encoded trims 29% of team; Inventiva halves staff

Fierce Biotech Layoff Tracker 2025: Encoded trims 29% o...

Feb 13, 2025  0

Pliant, Acelyrin resort to ‘poison pills’ as threat of Concentra buyout looms

Pliant, Acelyrin resort to ‘poison pills’ as threat of ...

Mar 14, 2025  0

Pfizer adds J&J, BMS vet James List to its executive roster as new chief internal medicine officer

Pfizer adds J&J, BMS vet James List to its executive ro...

Mar 7, 2025  0